Daymark Health advanced its value-based oncology strategy this week, emphasizing a payer- and provider-aligned cancer care model and expanding its leadership bench. The company is positioning itself as a partner-oriented platform that supports patients and families beyond traditional treatment.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Daymark highlighted a collaboration with Blue Cross & Blue Shield of Rhode Island and Brown University Health as a live example of its multi-stakeholder model. The initiative aims for a “win-win-win” among payers, providers, and patients, signaling growing validation of its approach in supportive and cost-conscious oncology care.
By referring to partners as “co-architects,” Daymark underscored that its model is co-designed with insurers and health systems rather than imposed on them. This design philosophy may ease implementation, support sustainability, and improve the likelihood of broader adoption in future markets.
The company also showcased its cancer care model at the National Healthcare Continuum Conference in Scottsdale, using a Connected Care Briefing session to spotlight its work across providers, payers, and patients. This visibility targets key decision-makers as value-based oncology and integrated reimbursement frameworks gain traction in the U.S. healthcare system.
On the organizational front, Daymark appointed Ryan Liefer as VP of Provider Growth, bringing experience from Oak Street Health, HCSC, Walgreens Health, Stellar Health, and Sylvan Health. His mandate is to scale provider partnerships nationwide and deepen engagement across the care continuum, supporting Daymark’s growth agenda.
Daymark further reinforced its community oncology ties by hosting clinicians and cancer experts at the Community Oncology Alliance conference alongside Oncology Ventures. Discussions centered on enhancing patient support and care coordination, and included remarks from former NFL player and cancer survivor Mark Herzlich.
Taken together, the week’s developments strengthen Daymark Health’s profile in value-based cancer care through strategic partnerships, expanded leadership, and targeted industry outreach. These moves collectively support its long-term effort to broaden adoption of its oncology care model and deepen its role in the oncology ecosystem.